drugset / Trial / NCT00404378
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a two period study of healthy adult subjects to characterize the effect of the dosing of ketoconazole on the the way the body reacts to a dose of GW679769, and to assess the safety profile of oral casopitant with and without ketoconazole. This study will consist of a screening period, two treatment periods and a post-treatment follow-up visit.
Timeline
- Start
- 2006-10-20
- Primary completion
- 2007-01-05
- Completion
- 2007-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 50 mg | Oral |
| Subject | Casopitant | Small molecule | 100 mg | Oral |
| Subject | Ketoconazole | Small molecule | 400 mg | — |